Sign inJoin waitlistJoin the waitlist

Paul Carpenter

Clinical Director, Long Term Follow-Up Clinical Service, Fred Hutch · University of Washington School of Medicine

Credentials: · · · ·

History

Long Term Follow-Up Clinical Service · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Pediatric Hematology Oncology
University of Washington-Seattle Campus
1992–1995
Sydney Children's Hospital
1989–1992
Concord Repatriation General Hospital
1988–1989
UNIV OF SYDNEY, SYDNEY, NEW SOUTH WALES
1984–1988

Research

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Blood · 2011 · 552 citations
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation · 2012 · Last of 13 authors · 500 citations
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality
Clinical Infectious Diseases · 2007 · 408 citations

Stephanie Lee
72 papers
Mary Flowers
68 papers
Paul Martin
63 papers
YI
Yoshihiro Inamoto
35 papers
BS
Bipin Savani
31 papers
JP
Joseph Pidala
28 papers
Carrie Kitko
27 papers
Corey Cutler
25 papers
Betty Hamilton
24 papers
Frederick Appelbaum
24 papers
Steven Pavletic
23 papers
MP
Miguel-Angel Perales
22 papers

Clinical trials

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
Principal investigator · Completed · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2008–2013
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2006
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2002–2010
Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
Study chair · Completed · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2004–2007